The examination of DU145 prostate cancer cells, in which USP2 is overexpressed, regarding induced cytotoxicity via treatment with five selected quinones (Fig. 6) disclosed that only compound 12 was (marginally) more potent than β-lapachone (18). This evidence concerns the gene USP2 and prostate carcinoma.